Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vera Therapeutics
Biotech
Analysts hail Vera's kidney drug as potential 'functional cure'
The durability of the effects seen in the phase 2b trial led Evercore ISI analysts to say “this feels like a ‘functional cure.'”
Nick Paul Taylor
Oct 28, 2024 9:27am
Cerevel swaps CEO—Chutes & Ladders
May 5, 2023 9:30am
Vera finally snags a win for Merck KGaA kidney disease castoff
Jan 3, 2023 4:01pm
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Jan 19, 2021 8:25am
